WallStreetZenWallStreetZen
Analyst Ranking
Bottom 4%
#4385 out of 4527 analysts
Average Return
-22.77%
Win Rate
32%6 out of 19
Risk vs Reward
Poor
Good

Tim Chiang's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Jasper Therapeutics IncJSPR
+107.34%$13.90$28.82
2023-08-10 -
2024-03-27
Buy
Ideaya Biosciences IncIDYA
+89.80%$12.06$22.89
2020-08-31 -
2021-08-30
Buy
Amphastar Pharmaceuticals IncAMPH
+62.69%$37.39$60.83
2022-07-28 -
2023-07-28
Buy
AlvotechALVO
+35.93%$9.88$13.43
2022-03-20 -
2023-03-20
Buy
Teva Pharmaceutical Industries LtdTEVA
+11.95%$18.50$20.71
2017-09-10 -
2018-01-18
Strong Buy

Tim Chiang Analyst Color

Get additional color on Tim Chiang's coverage of popular stocks

Tim Chiang's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Jasper Therapeutics IncJSPR
1Buy$70.00+142.89%Initiates Coverage On
8 months ago
Akoya Biosciences IncAKYA
1Buy$19.00N/AInitiates Coverage On
a year ago
Amphastar Pharmaceuticals IncAMPH
3Buy$44.00N/AInitiates Coverage On
2 years ago
Kala Bio IncKALA
2Buy$200.00N/AMaintains
2 years ago
AlvotechALVO
1Buy$15.00N/AInitiates Coverage On
2 years ago
Cyteir Therapeutics IncCYTT
1Buy$16.00N/AInitiates Coverage On
2 years ago
Protagonist Therapeutics IncPTGX
3Buy$40.00N/AUpgrades
2 years ago
Sab Biotherapeutics IncSABS
1Buy$18.00N/AInitiates Coverage On
2 years ago
Perspective Therapeutics IncCATX
1Buy$1.25N/AInitiates Coverage On
3 years ago
Pacira Biosciences IncPCRX
2Hold$66.00N/AMaintains
3 years ago
Repare Therapeutics IncRPTX
1BuyN/AN/AInitiates Coverage On
3 years ago
Ideaya Biosciences IncIDYA
1Buy$28.00N/AInitiates Coverage On
4 years ago
Verrica Pharmaceuticals IncVRCA
1Buy$21.00N/AInitiates Coverage On
4 years ago
Teva Pharmaceutical Industries LtdTEVA
3HoldN/AN/AUpgrades
6 years ago
Summit Therapeutics IncSMMT
1Strong Buy$33.00N/AInitiates Coverage On
6 years ago
Trean Insurance Group IncTIG
1HoldN/AN/ADowngrades
6 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.